Drug Shortage Report for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML

Last updated on 2024-09-20 History
Report ID 237153
Drug Identification Number 02193221
Brand name THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Common or Proper name THIAMINE HYDROCHLORIDE INJECTION 100MG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) THIAMINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 5 x 10mL vial / fiole
ATC code A11DA
ATC description VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-09-13
Actual start date
Estimated end date 2024-09-19
Actual end date 2024-09-17
Shortage status Resolved
Updated date 2024-09-20
Company comments There was a delay in the product's manufacturing. Product still available at CPDN.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-09-20 French Compare
v5 2024-09-20 English Compare
v4 2024-09-14 English Compare
v3 2024-09-10 French Compare
v2 2024-09-10 English Compare
v1 2024-09-10 English Compare

Showing 1 to 6 of 6